Evaluation of the Efficacy of the Live Attenuated Tetravalent Dengue Vaccine Against DENV-2 and DENV-3 Challenge

NCT03416036 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

NIH

Sponsor class

Conditions

Dengue

Interventions

BIOLOGICAL: TetraVax-DV-TV003 (TV003)
BIOLOGICAL: rDEN2Δ30-7169 (DENV-2)
BIOLOGICAL: rDEN3Δ30 (DENV-3)
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)